Gene Delivery Breakthroughs and Biotech Earnings
Kilder
- statnews.com: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price - statnews.com
- biopharmadive.com: Novo hikes guidance on Wegovy pill’s fast sales start - BioPharma Dive
- biospace.com: Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales - BioSpace
- biopharmadive.com: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline - BioPharma Dive
- biospace.com: Bayer ends multi-year M&A drought with up to $2.45B Perfuse buy - BioSpace
- bioworld.com: Bayer buying Perfuse for $300M up front in potential $2.45B deal - BioWorld News
- bioworld.com: Abdakibart phase II graded, puts Avalo in HS upper class - BioWorld News
- bioworld.com: Avalo’s IL-1 beta-targeting abdakibart scores in HS phase II - BioWorld News
- Nature: Engineering challenges and translational opportunities in emerging gene delivery platforms - Nature
- nature.com: Engineering challenges and translational opportunities in emerging gene delivery platforms - Nature
- bioengineer.org: Engineering Hurdles and Opportunities in Gene Delivery - Bioengineer.org
- Fiercebiotech: Ipsen scuttles liver disease candidates from Albireo acquisition - Fierce Biotech
- fiercebiotech.com: Ipsen scuttles liver disease candidates from Albireo acquisition - Fierce Biotech
- Biospace: Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements - BioSpace
- globenewswire.com: Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements - GlobeNewswire
- stocktitan.net: Jennison holds 1.71M shares in TARSUS PHARMACEUTICALS (TARS) — 4.0% - Stock Titan
- manilatimes.net: Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress - The Manila Times
- wikimedia: Photo by Unknown authorUnknown author / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.